饮食酸盐通过改善血液动力学,改善重塑和解决炎症来预防HFrEF心脏功能障碍
Miho Shimari1, Gaia Picozzi1, Ariela Boeder1
1Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Acta physiologica (Oxford, England)
|October 13, 2025
概括
食无机酸盐补充剂改善了心脏功能,并减少了小鼠心力衰竭中的纤维化. 早期的酸盐治疗通过增强氧化 (NO) 信号传递,提供了一个有希望的心脏保护策略.
科学领域:
- 心血管研究研究心血管研究
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 减少喷射分数 (HFrEF) 的心力衰竭涉及心脏功能受损,氧化 (NO) 生物可用性降低和炎症.
- 这些因素对HFrEF的发病和进展至关重要.
研究的目的:
- 调查饮食无机酸盐补充剂是否可以改善心脏功能并减少HFrEF中的不良心脏重塑.
- 为了确定酸盐补充是否在HFrEF的背景下增强NO信号通路.
主要方法:
- 利用两种HFrEF (心肌梗塞和横向大动脉收缩) 的小鼠模型.
- 在心肌损伤后4-6周服用酸盐或对照饮食.
- 通过心声学,光伏循环分析,组织学,肌肉学,Q-PCR和免疫光学评估心脏功能,血液动力学,纤维化,血管松和分子生物标志物.
主要成果:
- 无机酸盐治疗改善了静心和静心心脏功能,并增强了大动脉血管松.
- 酸盐补充剂显著降低了心脏纤维化 (替代性和反应性) 和炎症.
- 观察到过度缩,纤维化和炎症标志物的下调,与抗炎性标志物的上调以及M1-M2巨细胞两极分化.
结论:
- 心肌损伤后早期食酸盐补充剂在HFrEF中显示出显著的心脏保护作用.
- 酸盐增强心脏和血管功能,减少纤维化和炎症,支持其在HFrEF进展中的作用.
- 这突显了酸盐作为治疗策略的潜力,通过NO信号增强来改善HFrEF的结果.
相关概念视频
01:16Antianginal Drugs: Nitrates and β-Blockers
1.4K
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.4K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
932
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
932
01:30Heart Failure V: Medical Management
218
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
218
01:28Nitric Oxide Signaling Pathway
6.2K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.2K
01:20Angina V: Nursing Management
287
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
287
01:23Antihypertensive Drugs: Vasodilators
2.0K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.0K